SLAMF7 CART clinical trial - 4 sites 30 patients. | CARAMBA
Frontiers | Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies
Cancers | Free Full-Text | Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma | HTML
CAR T-cell therapy in multiple myeloma: more room for improvement | Blood Cancer Journal
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia: Molecular Therapy
CAR T-Cell: What you Need to Know | Int'l Myeloma Fn
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma | Haematologica
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells - ScienceDirect
Cureus | Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma | Gene Therapy
New CAR T-cell therapy extends remission in heavily relapsed multiple myeloma patients: Newsroom - UT Southwestern, Dallas, Texas
CAR T cell therapies for patients with multiple myeloma | Nature Reviews Clinical Oncology
Ask The Nurse: CAR-T cell treatments - Myeloma UK
CAR T-Cell Therapy Approved for Multiple Myeloma - NCI
Beyond our wildest dreams' – CAR-T therapies in multiple myeloma - The Pharmaceutical Journal
Hemato | Free Full-Text | Why Immunotherapy Fails in Multiple Myeloma | HTML
New immunotherapy sends multiple myeloma into remission
Frontiers | Dual Targeting to Overcome Current Challenges in Multiple Myeloma CAR T-Cell Treatment
CAR T-cell therapy in multiple myeloma: more room for improvement | Blood Cancer Journal
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges - ScienceDirect
CAR T-cell therapy in multiple myeloma: more room for improvement | Blood Cancer Journal
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma | Haematologica
CAR T-cell therapy for multiple myeloma: state of the art and prospects - The Lancet Haematology
